BrainCapture is a Danish startup developing a revolutionary medical technology aimed at the 4+ Billion people in emerging markets who lack consistent and affordable access to neurological diagnostics. This lack of access leads to millions of people going without diagnosis and treatment for conditions like Epilepsy.
We believe this significant global issue can be addressed by applying the tools of the 21st century - smartphones, connectivity, AI and automation - to the outdated medical technology and practices currently in use. We also believe that the vast disparity in access to care represents an opportunity.
We are creating an Electroencephalogram (EEG) device which is easy to use, telemedicine optimized, and AI assisted in order to offer EEG as a service throughout Africa, the Middle East, and Asia. The idea of an affordable, portable, connected EEG device has matured rapidly since BrainCapture was founded in 2019. Our small but dedicated team has validated the concept in trials in Guinea and Bhutan, tested prototypes at Filadelfia Epilepsy Hospital in Denmark and at Harvard Medical School, and undertaken usability testing in Kenya.
Our founding team consists of leading AI professors from DTU, a Harvard professor in Epilepsy, engineers with execution experience and strong senior investors. We have secured funding through investors and European grants for the next phase of our growth we have been awarded a 1M EUR Eurostars grant(2020), raised 500k EUR in seed capital (2021), and secured 2M EUR from the European Innovation Council via their Accelerator Award (2022) with this our development and roll out is fully funded through 2025.
We are currently expanding the team with several profiles to take us to the next level and deliver a device and technology stack that will change the lives of millions of people all over the world. While our approach to the EEG device is novel, we are not alone. A wave of innovation is sweeping the diagnostics industry. Join us to participate in a once-in-a-generation innovation.